Symptomatic stage C carcinoma of prostate. Traditional therapy

Of 119 consecutive patients with adenocarcinoma of the prostate, 54 patients had clinical Stage C disease and are the subject of this study. Of these 54 patients, 52 underwent transurethral prostatectomy and bilateral orchiectomy as their initial treatment; estrogens were not prescribed. The mean age of the patients with Stage C disease was seventy-three years, the average survival 6.4 years, and the five and ten-year survivals were 66 and 20 per cent, respectively. Stage C patients treated in this series did as well as those treated with radiation or radical extirpation.